The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aadi Bioscience Inc | Common | 00032Q104 | 1,192,398 | 509,572 | SH | SOLE | 509,572 | 0 | 0 | ||
Adverum Biotechnologies, Inc. | Common | 00773U207 | 21,210,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
Alpine Immune Sciences Inc | Common | 02083G100 | 20,794,175 | 520,505 | SH | SOLE | 520,505 | 0 | 0 | ||
Aligos Therapeutics Inc | Common | 01626L105 | 3,476,089 | 3,547,030 | SH | SOLE | 3,547,030 | 0 | 0 | ||
Allakos Inc | Common | 01671P100 | 3,764,880 | 2,988,000 | SH | SOLE | 2,988,000 | 0 | 0 | ||
ALX Oncology Holdings Inc | Common | 00166B105 | 47,053,535 | 4,220,048 | SH | SOLE | 4,220,048 | 0 | 0 | ||
Astria Therapeutics Inc | Common | 04635X102 | 32,781,055 | 2,329,027 | SH | SOLE | 2,329,027 | 0 | 0 | ||
Avadel Pharmaceuticals PLC | ADR | 05337M104 | 67,088,752 | 3,972,099 | SH | SOLE | 3,972,099 | 0 | 0 | ||
Bolt Therapeutics Inc | Common | 097702104 | 4,929,807 | 3,521,291 | SH | SOLE | 3,521,291 | 0 | 0 | ||
Codexis, Inc | Common | 192005106 | 1,354,623 | 388,144 | SH | SOLE | 388,144 | 0 | 0 | ||
Cogent Biosciences Inc | Common | 19240Q201 | 15,086,004 | 2,244,941 | SH | SOLE | 2,244,941 | 0 | 0 | ||
Compass Pathway PLC | SPONSORED ADS | 20451W101 | 13,378,560 | 1,608,000 | SH | SOLE | 1,608,000 | 0 | 0 | ||
Compass Therapeutics Inc | Common | 20454B104 | 7,040,926 | 3,556,023 | SH | SOLE | 3,556,023 | 0 | 0 | ||
Crinetics Pharmaceuticals Inc | Common | 22663K107 | 16,383,500 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
DBV Technologies SA | SPONSORED ADS | 23306J101 | 2,029,218 | 2,708,875 | SH | SOLE | 2,708,875 | 0 | 0 | ||
Delcath Systems, Inc. | Common | 24661P807 | 7,950,378 | 1,666,746 | SH | SOLE | 1,666,746 | 0 | 0 | ||
Dyne Therapeutics Inc | Common | 26818M108 | 46,421,511 | 1,635,136 | SH | SOLE | 1,635,136 | 0 | 0 | ||
Engene Holdings Inc. | Common | 29286M105 | 11,504,050 | 678,705 | SH | SOLE | 678,705 | 0 | 0 | ||
Genetron Holdings Ltd | ADS | 37186H209 | 10,899,925 | 2,708,056 | SH | SOLE | 2,708,056 | 0 | 0 | ||
Geron Corp | Common | 374163103 | 89,843,464 | 27,225,292 | SH | SOLE | 27,225,292 | 0 | 0 | ||
Harmony Biosciences Holdings Inc | Common | 413197104 | 87,517,774 | 2,606,247 | SH | SOLE | 2,606,247 | 0 | 0 | ||
Instil Bio Inc | Common | 45783C200 | 6,742,850 | 624,338 | SH | SOLE | 624,338 | 0 | 0 | ||
IO Biotech Inc | Common | 449778109 | 10,680,049 | 6,173,439 | SH | SOLE | 6,173,439 | 0 | 0 | ||
Olema Pharmaceuticals Inc | Common | 68062P106 | 21,210,329 | 1,873,704 | SH | SOLE | 1,873,704 | 0 | 0 | ||
Oric Pharmaceuticals Inc | Common | 68622P109 | 11,683,114 | 849,681 | SH | SOLE | 849,681 | 0 | 0 | ||
Precision Biosciences Inc | Common | 74019P207 | 63,395 | 4,675 | SH | SOLE | 4,675 | 0 | 0 | ||
Q32 Bio Inc. | Common | 746964105 | 6,305,959 | 370,068 | SH | SOLE | 370,068 | 0 | 0 | ||
Regulus Therapeutics Inc | Common | 75915K309 | 14,400,000 | 5,000,000 | SH | SOLE | 5,000,000 | 0 | 0 | ||
Rezolute Inc | Common | 76200L309 | 7,134,145 | 2,797,704 | SH | SOLE | 2,797,704 | 0 | 0 | ||
Savara Inc | Common | 805111101 | 10,399,849 | 2,088,323 | SH | SOLE | 2,088,323 | 0 | 0 | ||
Sera Prognostics Inc | Common | 81749D107 | 15,019,004 | 1,650,440 | SH | SOLE | 1,650,440 | 0 | 0 | ||
Silence Therapeutics PLC | ADS | 82686Q101 | 23,877,806 | 1,105,454 | SH | SOLE | 1,105,454 | 0 | 0 | ||
Sinovac Biotech Ltd. | SHS | P8696W104 | 76,346,000 | 11,800,000 | SH | SOLE | 11,800,000 | 0 | 0 | ||
Soleno Therapeutics Inc | Common | 834203309 | 360,294,380 | 8,418,093 | SH | SOLE | 8,418,093 | 0 | 0 | ||
Tarsus Pharmaceuticals Inc | Common | 87650L103 | 20,557,743 | 565,550 | SH | SOLE | 565,550 | 0 | 0 | ||
Terns Pharmaceuticals Inc | Common | 880881107 | 43,676,428 | 6,657,992 | SH | SOLE | 6,657,992 | 0 | 0 | ||
Tourmaline Bio Inc. | Common | 89157D105 | 13,554,098 | 591,882 | SH | SOLE | 591,882 | 0 | 0 | ||
Unicycive Therapeutics | Common | 90466Y103 | 4,788,810 | 3,470,152 | SH | SOLE | 3,470,152 | 0 | 0 | ||
Verastem Inc | Common | 92337C203 | 18,153,840 | 1,538,461 | SH | SOLE | 1,538,461 | 0 | 0 | ||
Verona Pharma PLC | SPONSORED ADS | 925050106 | 58,087,748 | 3,610,177 | SH | SOLE | 3,610,177 | 0 | 0 | ||
Viridian Therapeutics Inc | Common | 92790C104 | 29,385,405 | 1,678,207 | SH | SOLE | 1,678,207 | 0 | 0 | ||
Zai Lab Ltd | ADR | 98887Q104 | 8,509,792 | 531,198 | SH | SOLE | 531,198 | 0 | 0 |